Umbilical Cord Blood Donation: Public or Private?|
The authors review the progress of umbilical cord blood (UCB) banking technology; they also analyze the current data on pediatric and adult unrelated UCB, including the recent expansion of interest in transplantation for hemoglobinopathies, and discuss emerging studies on the use of autologous UCB for neurologic diseases and regenerative medicine. [Bone Marrow Transplant] Abstract
Visit our reviews page to see a complete list of reviews in the cord blood research field.
bluebird bio and Five Prime Therapeutics Enter into License Agreement for Novel Antibodies to Develop Chimeric Antigen Receptor T Cell Therapy|
bluebird bio, Inc. and Five Prime Therapeutics, Inc. announced that they have entered into an exclusive license agreement to research, develop and commercialize chimeric antigen receptor T cell therapies using Five Prime’s proprietary human antibodies to an undisclosed cancer target for hematologic malignancies and solid tumors. [bluebird bio, Inc.] Press Release
Pluristem Granted Key Cell Patents in Asia, Russia, Mexico, and Israel
Pluristem Therapeutics Inc. announced it has been granted patents covering cell manufacturing, pharmaceutical compositions and disease treatment in China, South Korea, Mexico, Russia, and Israel. [Pluristem Therapeutics Inc.] Press Release
From our sponsor:
Webinar: Brent Reynolds on the identification and characterization of neural stem cells. Watch now.